Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population

被引:19
|
作者
Bello-Lepe, Sebastian [1 ,2 ]
Francisca Alonso-Sanchez, Maria [1 ,2 ,3 ]
Ortega, Alonso [1 ,2 ,3 ]
Gaete, Marcelo [4 ]
Veliz, Marcela [4 ]
Lira, Juan [5 ]
Perez Salas, Claudia Paz [5 ]
机构
[1] Univ Valparaiso, Fac Med, Escuela Fonoaudiol, Vina Del Mar, Chile
[2] UCL, Psychol & Language Sci Div, London, England
[3] Univ Valparaiso, Fac Med, Ctr Invest Desarrollo Cognic & Lenguaje, CIDCL UV, Angamos 655, Vina Del Mar 2540064, Chile
[4] Univ Arturo Prat, Escuela Psicol, Iquique, Chile
[5] Univ Concepcion, Fac Ciencias Sociales, Dept Psicol, Concepcion, Chile
关键词
Montreal Cognitive Assessment; Mini-Mental State Examination; Mild cognitive impairment; Dementia; Cognitive screening test; Clinical neuropsychology; MINI-MENTAL-STATE; ALZHEIMERS ASSOCIATION WORKGROUPS; ASSESSMENT MOCA; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; EXAMINATION MMSE; IMPAIRMENT; DEMENTIA; RECOMMENDATIONS; DISEASE;
D O I
10.1159/000506280
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Montreal Cognitive Assessment (MoCA) is a sensitive screening instrument for mild neurocognitive disorder (mild NCD). However, cut-off scores and accuracy indices should be established using representative samples of the population. In this context, the aim of this study was to update the normative values, and diagnostic efficiency statistics of the MoCA to detect mild NCD in the Chilean population. Methods: This study included 226 participants from the north, center, and south of the country, classified into 3 groups: healthy elderly (HE; n = 113), mild NCD (n = 65), and major neurocognitive disorder (major NCD; n = 48). Results: The optimal cut-off score to discriminate mild NCD from HE participants was 20 points with a sensitivity of 82.8% and a specificity of 84.1%. The observed balance between sensitivity and specificity shows a good test performance either to confirm or discard a diagnosis. The cut-off between mild NCD and major NCD from HE participants was 19 points with 85.6% of sensitivity and 90.3% of specificity. Conclusion: Overall diagnostic accuracy can be considered as outstanding (AUC =0.904) when discriminating HE from both mild NCD and major NCD. These results showed that the MoCA is a suitable tool to identify mild NCD and major NCD. (c) 2020 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:105 / 114
页数:10
相关论文
共 50 条
  • [1] Standardized results of the Montreal Cognitive Assessment (MoCA) for neurocognitive screening in a Chilean population
    Gaete, M.
    Jorquera, S.
    Bello-Lepe, S.
    Mendoza, Y. M.
    Veliz, M.
    Alonso-Sanchez, M. F.
    Lira, J.
    NEUROLOGIA, 2023, 38 (04): : 246 - 255
  • [2] Mild Neurocognitive Disorder in the Climacteric with Montreal Cognitive Assessment
    Dorador-Gonzalez, Maria-de-Lourdes
    Orozco-Calderon, Gabriela
    REVISTA CHILENA DE NEUROPSICOLOGIA, 2018, 13 (02): : 9 - 14
  • [3] Validity and reliability of two alternate versions of the Montreal Cognitive Assessment (Hong Kong version) for screening of Mild Neurocognitive Disorder
    Wong, Adrian
    Yiu, Stanley
    Nasreddine, Ziad
    Leung, Kam-tat
    Lau, Alexander
    Soo, Yannie O. Y.
    Wong, Lawrence Ka-sing
    Mok, Vincent
    PLOS ONE, 2018, 13 (05):
  • [4] Neurocognitive screening in substance addicts: the Montreal Cognitive Assessment
    Rojo-Mota, Gloria
    Pedrero-Perez, Eduardo J.
    Ruiz-Sanchez de Leon, Jose M.
    Llanero-Luque, Marcos
    Puerta-Garcia, Carmen
    REVISTA DE NEUROLOGIA, 2013, 56 (03) : 129 - 136
  • [5] The Utility of the Montreal Cognitive Assessment as a Screening Measure of Mild Cognitive Impairment in Patients With Heart Failure
    Cameron, Jan
    Worrall-Carter, Linda
    Page, Karen
    Riegel, Barbara
    Stewart, Simon
    CIRCULATION, 2009, 120 (18) : S502 - S502
  • [6] The Montreal Cognitive Assessment: A Screening Tool for Mild Cognitive Impairment in REM Sleep Behavior Disorder
    Gagnon, Jean-Francois
    Postuma, Ronald B.
    Joncas, Steve
    Desjardins, Catherine
    Latreille, Veronique
    MOVEMENT DISORDERS, 2010, 25 (07) : 936 - 940
  • [7] Validity of the Montreal Cognitive Assessment (MoCA) as a Screening Test for Mild Cognitive Impairment (MCI) in a Cardiovascular Population
    McLennan, S. N.
    Mathias, J. L.
    Brennan, L. C.
    Stewart, S.
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2011, 24 (01) : 33 - 38
  • [8] Usefulness of the Polish versions of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination as screening instruments for the detection of mild neurocognitive disorder
    Sokolowska, Natalia
    Sokolowski, Remigiusz
    Oleksy, Eliza
    Kasperska, Paulina
    Klimkiewicz-Wszelaki, Karolina
    Polak-Szabela, Anna
    Podhorecka, Marta
    Kedziora-Kornatowska, Kornelia
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (05) : 440 - 448
  • [9] Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening
    Kim, Woo Jung
    Ku, Nam Su
    Lee, Young-Joon
    Ahn, Jin Young
    Kim, Sun Bean
    Ahn, Hye-Won
    Hong, Kyung-Wook
    Song, Joon Young
    Cheong, Hee Jin
    Kim, Woo Joo
    Kim, June Myung
    Namkoong, Kee
    Choi, Jun Yong
    Kim, Eosu
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 80 : 53 - 57
  • [10] Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder The Nor-COAST Study
    Munthe-Kaas, Ragnhild
    Aam, Stina
    Saltvedt, Ingvild
    Wyller, Torgeir Bruun
    Pendlebury, Sarah T.
    Lydersen, Stian
    Ihle-Hansen, Hege
    STROKE, 2021, 52 (01) : 317 - 320